Results 11 to 20 of about 187,354 (214)

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

open access: yesFrontiers in Pharmacology, 2018
Globally, gastric malignancy contributes to significant cancer-related morbidity and mortality. Despite a recent approval of two targeted agents, trastuzumab and ramucirumab, the treatment options for advanced-stage gastric cancer are limited ...
Vivek Kumar   +4 more
doaj   +1 more source

Propensity score matching method evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer [PDF]

open access: yesWaike lilun yu shijian, 2023
Objective To evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer by propensity score matching (PSM).
ZHANG Peichan, LUO Chunyang, WU Wenya, WU Zhenfeng, CAO Qinhong, CHEN Che, WU Xiaoyu, YAO Xuequan, LIU Fukun
doaj   +1 more source

Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer

open access: yesMolecular Therapy: Oncolytics, 2020
Advanced gastric cancer, especially scirrhous gastric cancer with peritoneal dissemination, remains refractory to conventional therapies. G47Δ, a third-generation oncolytic herpes simplex virus type 1, is an attractive novel therapeutic agent for solid ...
Kotaro Sugawara   +6 more
doaj   +1 more source

Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review

open access: yesFrontiers in Medicine, 2021
Gastric cancer is one of the most common cause of cancer related deaths worldwide which results in malignant tumors in the digestive tract. The only radical treatment option available is surgical resection.
Zhi-da Chen   +5 more
doaj   +1 more source

Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials

open access: yesBMC Research Notes, 2018
Objectives Advanced gastric cancer poses a therapeutic challenge worldwide. In randomised clinical trials, anti-VEGF has been reported as an essential agent for the treatment of advanced gastric cancer. This review aims at assessing the treatment outcome
Brian Mawalla   +3 more
doaj   +1 more source

Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application

open access: yesGastroenterology Research and Practice, 2016
Despite the great progress in the treatment of gastric cancer, it is still the third leading cause of cancer death worldwide. Patients often miss the opportunity for a surgical cure, because the cancer has already developed into advanced cancer when ...
Kaichun Li, Jin Li
doaj   +1 more source

Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition) [PDF]

open access: yesZhongguo aizheng zazhi
Gastric cancer is one of the most common malignant tumors, and over 70% of patients were diagnosed as advanced stage at the first visit in our country. For patients with locally advanced gastric cancer invading adjacent organs, the diagnosis and surgical
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology
doaj   +3 more sources

Is Preoperative Work-Up Colonoscopy Necessary for Patient with Gastric Cancer?

open access: yesThe Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016
Background/Aims: Recently, many studies have reported the incidence of colorectal neoplasm (CRN) to be increased in patients with gastric cancer. Thus preoperative colonoscopy is recommended for the screening of CRN.
Hee Chan Yang   +9 more
doaj   +1 more source

Application and challenge of immunotherapy in perioperative therapy of gastric cancer [PDF]

open access: yesZhongguo aizheng zazhi
Gastric cancer is one of the common malignant tumors of digestive system in our country. The proportion of patients in advanced and late stage is large, and the choice of perioperative treatment program is always difficult in clinic.
XUE Chi, GAO Peng, ZHU Zhi, WANG Zhenning
doaj   +3 more sources

Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer

open access: yesМедицинский совет, 2018
Gastric cancer is the third leading cause of cancer-related deaths worldwide. The prognosis of advanced gastric cancer remains poor despite therapeutic advances in recent decades.
T. A. Titova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy